Organization
Eisai Co., Ltd.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Eisai Co., Ltd.
... TOKYO KENILWORTH - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, 'Eisai') and Merck (NYSE: MRK), known as MSD outside of the United States ...
... that it is furthering its cooperation with the Japanese pharmaceutical company Eisai Co., Ltd. ("Eisai") with the signing of a new services agreement. This services ...
... Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, 'Eisai') announced today that it has ...
... TOKYO - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, 'Eisai') and Merck Co., Inc., Kenilworth ...
... Daniels Midland Company 7.5 DSM NV 7.4 Soham Organics Pvt. Ltd. 7.3 Eisai Food & Chemical Co. Ltd. 7.2 DSM Nutritional Products 7.1 BASF SE ...
... Eisai and Merck's fast-growing Lenvima has got a brand-new market—and Bayer's Nexavar now ...
... Tiama Chaar, Sanofi Genzyme; Prashant Desai, AbbVie; Katherine Jameson, Nanobiotix; Bernadett Mamone, Eisai; Savi Chadha, Supernus Pharmaceuticals; Shine Joseph, Janssen Biotech. All submissions were evaluated ...
... of the key players operating in this market are Bayer, Bristol-Myers Squibb, Eisai, and Exelixis. Collaborations for development, broader product portfolios, and regional expansion in ...
... Abbott, Abbvie, Actavis, Amgen, Astellas, AstraZeneca, Baxter, Bayer, Biogen Idec, BMS, Celgene, Eisai, Eli Lilly, Gilead, GSK, J&J, Kyowa Hakko, Merck, Mitsubishi, Mylan, Novartis, Pfizer, ...
... will have exclusive rights to utilise the results from the collaboration with Eisai to develop potential antibody treatments of Alzheimer's disease. The company said that ...
Subscribe now for full coverage on Eisai Co., Ltd.
Start My Free Trial